Objective: People exposed to beryllium compounds are at increased risk of developing
beryllium sensitization and chronic beryllium disease (CBD). The purpose of this short …

Beryllium manufacturing processes are associated with the immune-mediated chronic
beryllium disease (CBO). Recent workplace epidemiological studies have been relatively …

Beryllium exposure can cause a granulomatous lung disease in workers who develop a
lymphocyte-mediated sensitization to the metal. Workers in diverse industries are at risk …

Chronic beryllium disease is an occupational lung disease that begins as a cell-mediated
immune response to beryllium. Although respiratory and engineering controls have …

The blood beryllium lymphocyte proliferation test is used in medical surveillance to identify
both beryllium sensitization and chronic beryllium disease. Approximately 50% of …

Controlling beryllium inhalation exposures to comply with regulatory levels (2 μg m− 3 of air)
does not appear to prevent beryllium sensitization and chronic beryllium disease (CBD) …

The primary beryllium industry has generated a large amount of data on airborne beryllium
concentrations that has been used to characterize exposure by task-specific activities, job …

Exposure to beryllium in the workplace can result in beryllium sensitization (BeS) and
chronic beryllium disease (CBD). Previous studies indicate that the presence of a glutamic …

The use of beryllium in industrial settings in the 1930s and 1940s resulted in reports from
Europe [1] and Russia [2, 3] that documented cases of skin and lung disease in beryllium …

We conducted a medical screening for beryllium disease of 577 former workers from a
beryllium processing facility. The screening included a medical and work history …